Virbac has launched Inflacam, a meloxicam-based NSAID for the alleviation of pain in both acute and chronic musculo-skeletal disorders in dogs and horses.
Inflacam is presented both as an oral suspension and as a chewable tablet for dogs. The suspension is available in 200ml, 100ml, 42ml and 15ml sizes with a measuring syringe provided. The tablets come in two sizes - 1 mg and 2.5 mg - and are available in packs of 100. It is available for horses as an oral suspension.
Virbac Product Manager Chris Geddes MRCVS, said: "Virbac is well known for launching innovative products in areas such as dermatology and reproduction but we also aim to support practices by offering tried and trusted practice 'standards' for everyday use. Inflacam fits this brief well - meloxicam is the most commonly-used NSAID in dogs and we are delighted to add it to our range."
For more information contact your territory manager or call Virbac on 01359 243 243.
Those veterinary surgeons being audited are being asked to share their records for 2013 to 2015 by either allowing the College to access their online Professional Development Record or by sending the RCVS a copy of their CPD record cards. The deadline for sharing records is Friday 14 October 2016.
The audit is focused on six groups:
If any of the veterinary surgeons who have been audited are found to be non-compliant (ie. less than 105 hours of CPD over a rolling three-year period), they will be asked to explain why and send a plan stating how they will make up the hours in order to become compliant.
The College says it is also keen to remind veterinary surgeons that CPD encompasses a wide range of recorded activities, which can be clinical or non-clinical, including private reading/study, webinars, mentoring, clinical audit and discussion groups as well as attending seminars and workshops.
More information about what counts as CPD can be found at www.rcvs.org.uk/cpd
Those with any questions about the auditing process or what constitutes CPD can contact Jenny Soreskog-Turp, Education Officer at the College, on cpd@rcvs.org.uk
Ed's note: Don't forget to claim your VetSurgeon.org CPD certificate detailing time you've recorded reading content and taking part in qualifying discussions on the site. Click 'My Account' and then the 'CPD' tab to view your records and create your certificate.
Intraperitoneal and incisional analgesia in small animals: simple, cost-effective techniques1, considers the findings and limitations of recent studies and makes recommendations on the use of IP and incisional analgesia in companion animals.
Paulo Steagall, lead author of the paper said: "Based on current evidence and a consensus of the WSAVA-GPC members, it is recommended that IP and incisional analgesia should be used for abdominal surgery such as intestinal foreign body removal, splenectomy, etc. These techniques can be particularly useful in high-volume sterilisation programmes due to their safety and cost effectiveness. They should never be administered as stand-alone analgesic techniques, but rather should be used in addition, as part of a multimodal analgesic plan with opioids and nonsteroidal anti-inflammatory drugs (NSAIDs)."
The review says that current literature on IP and incisional analgesia has several limitations including the use of different doses, drugs and volumes of local anaesthetic. Furthermore, acute pain assessment was performed using a number of different pain scoring systems with variable validity, by a number of different people which may introduce bias. Further studies are therefore warranted to continue to investigate the use of IP and incisional analgesia in a number of clinical scenarios.
Nicholas Jeffery, editor of JSAP said: "Local anaesthetics are inexpensive and not limited by geographic availability; this review supports their use to manage perioperative pain as part of a multimodal management approach."
The full article can be found in the January issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13084
For further information relating the use of local anaesthesia and the management of perioperative pain, the BSAVA is advising veterinary surgeons to consult a text such as the BSAVA Guide to Pain Management in Small Animal Practice.
Reference
The programme is the first in a new series of ‘Accelerated’ courses from the company, designed to support those starting out on their postgraduate learning journey or experienced vets who want to refresh their knowledge in a specific subject.
The Accelerated Emergency and Critical Care programme comprises 15 modules covering pathophysiology, diagnosis, management and current treatments.
The modules are delivered on a weekly basis and delegates can study at their own pace. Delegates can also access all the modules for a 12-month period so they can revisit the contents as necessary.
In addition to the modules, delegates have access to a discussion forum and four live sessions with Specialists for clinical case discussions.
At the end of the course, delegates can take a Foundation Certificate from the International School of Veterinary Postgraduate Studies (ISVPS).
The programme was developed by Specialist veterinarians, both Fellows and Members of the Australian and New Zealand College of Veterinary Scientists in Emergency and Critical Care, from Improve International’s Australian Partner, the Animal Emergency Service.
David Babington MRCVS, Business Development Director at Improve International, said: “The growing interest we are seeing from veterinarians around the world in updating their knowledge as we prepare to emerge into the post-COVID world, was the catalyst for the creation of our new Accelerated online course range.
"The Accelerated Emergency and Critical Care Programme is ideal for veterinarians at all stages of their career. It is an example of the ways we are delivering on our strategy of significantly expanding our e-learning portfolio and harnessing technologies, including video teaching and virtual/augmented reality, to offer a more engaging, affordable, accessible and rich learning experience to veterinary professionals around the world."
Alex is applying the data science he uses in his day job to help local vets at the Olive Ridley Project care for the ancient reptiles.
Six of the seven species of sea turtles are endangered due to human behaviour, many of them killed by poachers for their shells, eggs and meat.
They're also affected by the increasing volume of plastic waste in the sea.
Alex, who normally spends his time leading a team of business intelligence engineers and analysts who provide insights in finance, HR and clinical event reporting, is setting the charity up with practice management software to help it capture clinical records and track the sea turtles.
Alex said: "We’ll be setting up the software, making sure the vets can operate it and then adding all their existing data to it. We’re giving them a powerful tool to capture clinical records and manage turtles over a long period of time.”
“These valuable creatures are hugely important to marine ecosystems and have travelled our seas for the last 100 million years, so I’m delighted to be able to play a part in their conservation.”
For more information on the Olive Ridley Project, visit https://oliveridleyproject.org.
Boehringer Ingelheim Vetmedica has launched new, more palatable Metacam Chewable Tablets.
According to the company, the tablets are proven to be taken by 90% of dogs voluntarily1 and 80% will even take them from the floor1 which aids compliance. Available in pop-through blister strips of seven for easy dispensing and administration, the 1mg and 2.5mg Metacam Chewable Tablets are packed in boxes of 84 and priced the same per tablet as the current tablet range.
Claire Fowler, companion animal marketing manager at Boehringer Ingelheim, said: "The existing Metacam Chewable Tablets are readily accepted by most dogs. However, to appeal to as many dogs as possible, we have launched an even more appetising 'beefed up' meaty flavour."
For further information on the new flavoured Metacam tablets, including special offers, please contact your Boehringer Ingelheim territory manager or call 01344 746959.
The webinars will be presented by specialists in their respective fields; small animal oncologist Sara Verganti and clinical pathologists Francesco Cian and Roberta Rasotto.
Each 30-minute session will focus on a specific aspect of MCT diagnostics followed by a multidisciplinary Q&A. The sessions, which all start at 7:30pm, are:
Dr Neil Mottram MRCVS, Technical Product Manager at Virbac said: "Mast cell tumours are the most common form of canine cutaneous neoplasia, although relatively simple to identify, knowing what diagnostic steps to take can be challenging. We believe this truly comprehensive bite size mini-series will provide vets with the confidence to navigate the diagnostic approach for their next MCTs."
For more information, contact your Virbac Territory Manager.
The practice is now accepting dental referrals, including for dental, oral and maxillofacial surgery.
Hannah said: “I am proud to join the Fitzpatrick Referrals team to extend their referral offering to include this very important aspect of small animal veterinary treatment.
"Working alongside a world-class team with state-of-the-art facilities is a fantastic opportunity.”
https://www.fitzpatrickreferrals.co.uk/services/dentistry/
Noelle Lowry, a marathon-running vet from Lichfield has raised almost £2,500 for the RCVS Trust in the London Marathon.
Noelle beat her fundraising target of £1,500, to raise money for the Trust to use in its work to support veterinary education and research, and in providing library and information services.
She finished 4,594 out of the 11,037 women runners in the London Marathon, taking 4 hours and 36 minutes to run the 26.2 mile long course - and beating her time last year in the New York marathon.
Noelle said: "A lot of people chipped in at the last minute - my mum has been organising people back home in Ballymena and my friends and colleagues have all put their hands in their pockets - so a huge thank you to all of them.
"I'm a great fan of the RCVS Trust. It's not one of the big charity brands but the grant funding for veterinary research can really make a difference to animals - and we can all use the library and online resources - so I wanted to give it some help."
Click here for more about the work of the RCVS Trust
Owners are being asked to provide a photo or video and a brief description that capture what it is like to live with and care for an older dog.
Dr Carri Westgarth, a senior lecturer in human-animal interaction at the University of Liverpool, has been awarded a citizen science grant from PetSavers to run the project. She plans to use the information gathered to help develop a ‘Canine Ageing and Wellbeing’ tool for use in veterinary practice.
Carri said: “Dogs are living up to twice as long as they did 40 years ago and there are implications for senior dogs’ healthcare and wellbeing.
"As life expectancy increases, so does the amount of time the dog may spend in poor health. It may be difficult for us to distinguish between the signs of serious age-related diseases and normal age-related changes in our dogs."
PetSavers says the data will contribute to our investigations of owner expectations, experiences and attitudes to ageing in dogs, including preventative care and general understanding of normal and abnormal changes during ageing.
Carri added: "Improving discussions between owners and veterinary professionals about senior dog care will help to increase owner understanding and involvement in care decisions for their pet. The resulting early detection of health problems should bring significant improvement to the quality of life of senior pets and the dog-owner relationship.
"Any adult UK residents who (currently or recently) live with an aged dog/s of any breed/s or health status are encouraged to participate by choosing an image or short video and telling us about it."
The research team will then analyse the submitted text and media for common themes. They may also use anonymised selected quotes to illustrate important findings in research publications such as scientific papers or conference presentations.
If you know any owners who might like to participate, do share this link with them: https://bit.ly/PetSaversOAPsPhoto
For more information, visit: https://www.petsavers.org.uk/our-research/oldagepets
Data collection will close on Friday 10th July 2020.
Vets Now, the Out Of Hours emergency vets has announced the launch of Winchester's first dedicated 24/7 pet ambulance service.
Specifically designed for the comfortable and secure transport of all small animals, the new state-of-the-art ambulance is fully kitted out with the latest in emergency equipment.
After completing a course of rigorous training, the fully trained ‘Petamedics' (the animal equivalent of Paramedics), took to the streets of Winchester earlier in the month.
Gareth Roscoe, Vets Now Ambulance Service Team Leader said: "This service will make a real difference to animals in a distressed or critical situation. We've responded to a variety of cases over the past few weeks; one of the most recent ones being a nine week old puppy who was receiving emergency treatment at the Vets Now clinic in Winchester after his owner accidentally fell on him. Charlie was brought to the clinic collapsed and unresponsive with signs of head trauma. The vets set up an intensive treatment plan for him and by the morning, he was almost back to normal and we took him back to his daytime vet.
"The ambulance service provides owners in the Winchester area with the safest and fastest method of transporting their pets to get medical treatment twenty-four hours a day, seven days a week. What's more, the service is also available to owners who have routine transportation problems; so whether owners and their pets are visiting their clinic for a veterinary appointment, attending a referral centre or even going to the groomers, the Vets Now Ambulance offers them a reliable solution to all their pet transportation needs."
The ambulance is a significant new addition to the already established Vets Now Emergency Clinic which is based at the Mildmay Veterinary Centre, Easton Lane in Winchester. Caroline Hirst, Senior Veterinary Surgeon at the emergency clinic commented; "The dedicated 24 hour ambulance has already been called out to help several of our clients ahead of its official media launch on 25 September. As an emergency clinic, we often admit patients overnight, and a real plus of having the ambulance is that we can ensure that pets can be returned to their regular vet or back to their owner in the morning safely and with the minimum of fuss. From experience, Vets Now knows that there are regular occasions when owners are afraid to move their pet if it is unwell or has been involved in an accident. We hope that being able to offer the ambulance service will be of great benefit not only to pets but also to owners, giving them peace of mind that their pet is being cared for and transported in a safe environment until it receives the necessary veterinary treatment at the clinic."
Pfizer Animal Genetics is expanding its presence in the UK with the appointment of a dedicated team.
The company says it will use state-of-the-art genetic technology to improve the health, welfare and productivity of animals, and that the move comes at an exciting time for genetic research, as complete sequencing of the bovine genome has resulted in explosive growth of the possibilities.
As well as being able to provide tests addressing parentage (SireTRACE) and traceability (SureTRAK), Pfizer Animal Genetics can also help farmers identify the genetic potential that each animal has to produce tender, well marbled meat and to perform at optimal feed conversion efficiency (GeneSTAR) - vital management information that can improve profitability and enable effective decision making in long term breeding plans.
The company promises there is more to come, with exponential growth in the identification of genetic markers, which will allow the imminent introduction of new tests set to provide much more detailed predictive information about individual animals - all available virtually from birth onwards.
Richard Chew (above right) is Customer Service Manager and the first port of call for anyone with questions about pricing & submission forms, samples and reports. Richard grew up in rural Lancashire and went on to study at the University of Bristol. Since graduation his career has taken him through a variety of scientific and customer facing roles. He has worked for Pfizer Animal Health for six years in the clinical development of vaccines and pharmaceuticals for livestock and is looking forward to the new challenges of the genetics business. Richard is based in Pfizer's Surrey office and can be reached on 08345 3037398 or PfizerAnimalGenetics-EU@pfizer.com.
Mike Marron and Peter Quigley are Dairy Sales Manager and Beef and Sheep Sales Manager respectively and will be the contact points for breed associations, organisations and individuals who want to discuss how genetic assessment and identification can help assure the quality of a breed or herd. Mike has an honours degree in biological and biochemical science and a decade of experience in the animal health industry, with special interests in fertility and calf management. Peter also comes from the animal health industry and is looking forward to continuing the company's work with the Aberdeen Angus Society as well as developing programmes for other beef breed societies.
Mike or Peter will be in attendance at various agricultural shows across the UK including Agrilive, the South West Dairy Show, Surecalf, Agriscot, Thainstone Christmas Classic, the Welsh Winter Fair, The Great Yorkshire Show and the Northern Ireland Winter Fair, where they will be explaining how genetic testing can make a contribution towards improving the brand value of a breed and shortening the time frame to allow better management decisions to be made.
Dr Gary Evans is Technical Services Manager and will be providing detailed advice on how to improve pedigree herd books, the interpretation of results of genetic testing and detection of certain genetic diseases. Gary is a geneticist with fourteen years experience in the application of genomics to livestock and joins Pfizer Animal Genetics from PIC/Genus.
The British Veterinary Association has announced that it has almost halved the cost of attending its annual Congress this September.
According to the BVA, the decision was made to demonstrate its commitment to providing high-quality, affordable CPD.
The two-day event will now cost £150 +VAT for members and £300 +VAT for non-members for up to 11 hours of small animal CPD provided by the University of Liverpool.
The choice of topics includes:
The BVA says all the lectures will be delivered by leading experts in their field.
Alongside the clinical CPD programme BVA will run its contentious issues stream with discussions around the impact of women on the profession, horses for sport and the use of antimicrobials.
BVA Past President and small animal vet Harvey Locke worked with the University of Liverpool to create the clinical CPD programme. He said: "With a small animal clinical programme provided by the University of Liverpool, the BVA this year not only provides world-class CPD at Congress but it also comes at a fantastic price.
"BVA is committed to providing high-quality CPD to our members at affordable rates. We look forward to welcoming vets to Liverpool in September for our great value CPD programme."
BVA Congress takes place in Liverpool on 27-29 September at the Merseyside Maritime Museum.
The full programme and further information is available at www.bva.co.uk/congress.
Novartis Animal Health has announced that it has assumed marketing responsibilities for the joint health supplement Cosequin in the United Kingdom and Ireland.
Cosequin, which contains glucosamine and chondroitin sulfate, is available in a range of presentations for dogs, cats, and horses.
The product, which was previously marketed by MSD, is the leading joint health supplement among veterinary surgeons in the US and Europe.
Novartis says Cosequin is an important addition to its Orthopaedic Health Category, which in 2009 introduced Onsior (robenacoxib), the first tissue-selective pain relief for cats and dogs.
Gaynor Hillier, General Manager UK & Ireland Novartis Animal Health said: "Our strategic intent is to expand our presence in orthopaedic health to address prevention, diagnosis, and treatment in a more comprehensive manner. Cosequin represents an important step toward achieving this objective".
Cosequin is available from Novartis Animal Health in the United Kingdom and Ireland, from licensed veterinary wholesalers. For more information on Cosequin, contact your Novartis Animal Health Territory Manager.
Led by clinicians from Davies Veterinary Specialists, the Royal Veterinary College, and Willows Veterinary Centre and Referral Service, the study assessed the proportion of metronidazole use that was prescribed for non-antimicrobial purposes, and the rationale for it.
A survey was completed by 138 veterinarians, primarily in the UK and working in primary care small animal practice, who treated 332 cases (285 dogs and 47 cats) with metronidazole.
In 42% of cases, metronidazole was selected exclusively for non-antimicrobial targeted therapy, and was most commonly prescribed to treat acute diarrhoea, chronic diarrhoea, or giardiasis.
This, say researchers, is despite recommendations that antimicrobials are very rarely warranted for the management of acute and chronic diarrhoea.
The most common rationale cited by vets to justify metronidazole use was its supposed anti-inflammatory or immunomodulatory properties.
Other reasons included: treatment of suspected or confirmed anaerobic or susceptible bacterial infection, the patient being systemically unwell or having severe disease, treatment of protozoal infections, experiencing a previous positive outcome in a similar case or the same patient, anti-diarrhoeal action and owner or practice expectations.
Dr Justin Ng, lead author of the study, said: “These insights are alarming given that such practices frequently deviate from current antimicrobial use guidelines, potentially contributing to ongoing challenges with antimicrobial resistance and adverse effects on gastrointestinal health.”
https://onlinelibrary.wiley.com/doi/10.1111/jsap.13910
If you're attending BEVA this September you can win a place on the CEVA-sponsored Equine Ski-PD break in January 2010, combining a couple of days of first class Continued Professional Development (CPD) with some excellent skiing in the Italian Alps.
The course runs from 13-17 January 2009 and the CPD will be spread over five sessions, equating to two-and-a-half days. Equine vets Jane Boswell, Henry Tremaine, Professor Bruce McGorum, Professor Peter Clegg and Dr Tim Brazil will cover the topics of tendonitis, wound management, ophthalmology, internal medicine and joint disease.
Skiing will be at Courmayeur, a traditional Alpine village on the Italian side of Mont Blanc, where all levels of ability, from beginners to experienced off-piste skiers, can be catered for.
To win your place, which includes flights and four nights b&b accommodation, simply visit the CEVA stand at BEVA and answer a questionnaire on Tildren®, CEVA's bisphosphonate-based treatment for equine bone disease, based on information provided via a short film loop that will be running on the stand.
For further information on equine Ski-PD contact the organisers: ben.mayes@equinevetpractice.co.uk or henry.tremaine@bristol.ac.uk
Captains Nicola Housby-Skeggs and Claire Budge, the first two members of the Royal Army Veterinary Corps (RAVC) to achieve the RCVS Certificate in Advanced Veterinary Practice (CertAVP), have been presented with their certificates at Belgravia House.
The two Captains were visiting the RCVS as part of a 'Meet the RCVS Day' organised for a group of Officers from the RAVC. The Captains were presented with their Certificates by Vice-President Peter Jinman.
Capt Nicola Housby-Skeggs had completed a mixture of small animal and equine modules in order to achieve her Certificate, and was positive about the modular approach. She said: "It's reassuring to know you can have a break if you need to. The compulsory module on professional key skills was also more useful than I had anticipated, as it focused on aspects that you don't really have time for at vet school, such as management, and health and safety."
Meanwhile, Captain Claire Budge appreciated the fact that many of her modules could be completed via distance learning. She said: "It was great that I could continue with my studies even when serving in Afghanistan. My only regret is that when I started the Certificate back in 2008, there wasn't the range of modules available that there is now. For example, I would like to have done one of the new Animal Welfare, Ethics and Law modules. However, there is no reason why I can't just take this as continuing professional development - that's the benefit of the modular approach."
More information about the CertAVP can be found at www.rcvs.org.uk/modcerts.
'Meet the RCVS Days' give members of the veterinary team the opportunity to visit the College and find out what goes on behind the scenes. If you would like to join a future event, please let Fiona Harcourt know, on f.harcourt@rcvs.org.uk. Reasonable travel expenses are paid.
John Alborough presented the awards at the event. Liz Rawlings from Dechra said: "It was certainly a whirlwind at this year’s LVS and we are delighted to have scooped such a prestigious award." Zoe Appleyard-Ley, Co-Founder and Managing Director at Rockster Superfood for Dogs said: "We were so excited by the response Rockster had at the London Vet Show, and thrilled to have been given the award by VetSurgeon.org."
The three presentations, which are between 30 minutes and an hour in length, are aimed at vets but may also be of interest to veterinary nurses. They cover: ‘Topical therapy in canine atopic dermatitis’ and ‘Antimicrobial resistance’ presented by Dr Tim Nuttall and ‘Emotional considerations in dealing with dermatology cases’ by Dr Sarah Heath.
The presentations will be available for download from 7th June 2021, and viewers will be able to enter into a prize draw to win a £50 Love2Shop voucher and a free Cytology Manual.
To pre-register, visit: https://www.thewebinarvet.com/pages/ceva-dermatology-tea-time-top-ups-bite-size-cpd-sessions/
The Disciplinary Committee of the RCVS has approved an application for restoration to the Register from an Oxfordshire veterinary surgeon who had been struck off for false certification.
In November 2007, the Committee decided that Mr John Williams, of the Avonvale Veterinary Practice in Ratley, near Banbury, should have his name removed from the RCVS Register, having found him guilty of disgraceful professional conduct. Mr Williams had admitted signing export health certificates for three horses in October 2006 to state that they had received negative test results for the contagious equine metritis organism, before these results were actually available.
At the time, Mr Williams was working in his capacity as an Official Veterinarian (OV) for DEFRA and he had previously been suspended from his official duties on three separate occasions, on the basis of export certification irregularities. It was accepted that Mr Williams had not been dishonest, but his approach to certification was described by the Disciplinary Committee as "either irresponsible or cavalier or both".
In December 2007, Mr Williams appealed against this decision to the Privy Council but this was dismissed at a Hearing the following June. He was then removed from the Register in July 2008.
When the Committee met on Monday to consider Mr Williams' application, they heard oral and written supporting evidence from veterinary surgeons and equine clients, and oral evidence from Mr Williams himself. The Committee was satisfied that Mr Williams accepted its previous findings and fully understood their seriousness. He described his removal from the Register as a "salutary experience" which had been highly significant for him and his family, both financially and emotionally.
The Committee stated: "Although the decision of the Committee to remove [Mr Williams] from the Register sent a clear message to the profession of the importance of certification, it should be emphasised that his removal was the consequence of his actions in signing certificates which he could not verify. This followed three previous occasions on which he had similarly signed certificates when he should not have done so."
However, the Committee was satisfied that Mr Williams would not in future sign certificates when he should not do so, even under severe client pressure. It was impressed with the continuing professional development he had undertaken whilst off the Register and noted that no questions had been raised over his conduct during this time.
It concluded that Mr Williams fully understood the importance of accurate certification and that restoring his name to the Register therefore posed no risk to animal welfare. Neither the public nor the profession would benefit from Mr Williams staying off the Register for a further period.
Alison Bruce, Disciplinary Committee Chairman, said: "We would like to make it clear that we always find it distressing to remove clinically competent veterinary surgeons from the Register because of an irresponsible and cavalier attitude towards certification. This would not be necessary if veterinary surgeons were to follow the Twelve Principles of Certification annexed to the RCVS Guide to Professional Conduct."
The Committee then approved Mr Williams' application and directed that his name should be restored to the Register.
To use the service, practices have to register for VetsDeliver via Easy Direct Debit (which handles payments), then configure the system for the number of consultation rooms needed and to add practice branding. The first consultation room costs £69 per month, with discounts for subsequent rooms.
Practices can promote the service to pet owners by sharing a link for appointments via social media, the practice website, or a mail out to clients.
Clients then follow the shared link, complete a form and book a consultation slot.
After the consultation, the practice can email a link to the pet owner so that they can pay for any medication.
Adrian Tantrum (that must have been quite a cross to bear at school), Head of the Companion Animal Business Unit at MSD Animal Health said: "As market leaders, with brands such as Bravecto, Nobivac and Caninsulin, we want to help practices adapt to the new normal.
"We have listened to feedback from practices around what they want from a telemedicine platform and worked with EDD to create a simple and easy to use service. This will allow practices to provide pet owners with the support they need, whether it be their parasiticide prescriptions or providing continuity of care for diabetic patients, and will of course bring much-needed cash flow into their practices.
"We've chosen Zoom for the video capabilities as it is one of the most popular video conference apps with millions of users worldwide, so we know it's familiar to most pet owners."
Adrian added: "As we all adjust to new ways of working we are putting in place a whole series of new services for practices that will help bring them closer to their clients and allow them to continue to provide pet owners with the expertise and support they need. Being able to see a vet 'face-to-face', if not in the flesh, will be reassuring for a lot of pet owners who will be worrying about both new and on-going conditions."
For more information, contact your MSD account manager.
The researchers say that the findings pave the way to generating new and important information about the development chronic kidney disease (CKD) and hypertension (HTN) in cats.
The RVC says that about 30% of cats aged 10 years or older have CKD, which equates to approximately 600,000 in the UK.
Of these, about 40% will also have hypertension.
The research team was led by principal investigator at the RVC, Dr Rosanne Jepson, alongside joint first author from Queen Mary University of London, Dr Helen Warren, and Professor Patricia Munroe.
The team examined the archives of 1,022 domestic cats seen at both the RVC’s Beaumont Sainsbury Animal Hospital and Bow PDSA Pet Hospital since 1992, looking for genetic associations with CKD and HTN using a genome-wide association study (GWAS) approach.
The GWAS approach used a special feline array to characterise over 63,000 genetic differences across the feline genome.
The team examined the influence of different genes on disease traits which may point to new ways of treatment as the pathways and proteins controlled by these genes can indicate novel mechanisms for disease development.
Researchers say that this study method has historically been used for rarer and breed-specific conditions where single genetic mutations might be occurring.
However, the findings show it could now be used to generate new information about common and complex diseases which are likely to be the result of genetic, lifestyle and environmental risks.
Rosanne Jepson, Principal Author of the paper and Associate Professor in Small Animal Internal Medicine at the RVC, said: “This was an exciting opportunity to explore potential genetic influences on the development of chronic kidney disease and systemic hypertension in cats, collaborating with key opinion leaders who work and have published extensively in this field in human medicine.
“These conditions are complex - meaning that there are many factors relating to genetics, lifestyle and environment that cumulatively determine whether an individual may develop either CKD or hypertension in their lifetime.
“This study has shown us, as proof of concept, that large scale genomic studies will be important for understanding the pathogenesis of such complex disease conditions and may help to identify novel pathways as targets for diagnosis and management in the future.”
The course has been put together by the charity's Investigations Team with the help of Mark Naguib BVMS(Hons) CertAVP(ZooMed) MRCVS.
The course has been designed to help you identify animals which have been targeted by illegal shooting, trapping and poisoning, and how to make sure valuable evidence is preserved for any investigation by the police.
The course includes:
The course is open to anyone in veterinary practice, and is worth 2 hours CPD: https://www.rspb.org.uk/rspb-vet-cpd
VetCT says the app, which offers round the clock, rapid access to specialist support, aims to bridge the existing gap for those clinical cases where specialist input is desired, but for which full referral may not be ideal or possible.
It is also hoped that the new service will reduce the amount of time that GPs currently have to spend seeking further clinical advice, currently estimated at 10 hours per week, and reduce the amount of advice that Specialists currently give for free, estimated at 5 hours per week.
Using the app, GPs can send all the relevant information for the consultation, including the history, test results, videos and photos to Diploma-holding specialists across the entire range of specialties, direct from their mobile phone.
They can then choose whether to get an immediate call-back or text chat, a written report or a virtual appointment.
Victoria Johnson, co-Director, said: “Our mission is to help every vet be the best and feel their best every day. Behind the app we have a committed team of over 50 employed specialists, plus 100 radiologists and a full customer support team ready to respond to enquiries.
"All our specialists also work in clinical roles and previously have worked in first opinion practice, and we have so much respect for the challenges our general practitioner colleagues face.
"We want to make their lives that little bit easier, supporting them – with empathy – in giving the best care to complex cases where referral may not be an option.
"We also want to provide pet owners with access to specialist care for their pets, where cost or travel may preclude them from seeing a specialist at a referral centre.”
In addition to the consultation fee, there's an annual practice membership fee of £200 which is reduced for locum vets. VetCT says practices may choose to charge fees on to clients, or some practices may decide to absorb the costs for the support value it offers their clinicians.
VetCT says it will also gifting additional credits to help support vets who may benefit from a helping hand, such as those returning from extended leave, moving to different species areas, or new graduates.
The service is designed to complement existing specialist services. Victoria added: “We recognise the vital importance of physical referrals, and this service in no way replaces that. Indeed, we have started to see evidence that using the app will lead to more patients getting physically referred for the right reasons, at the right time, with the right information.
"However, we also know that many vets and specialists are under huge time pressure. Many specialists felt they were unable to do a good job of dealing with advice queries alongside their busy day job – much as they wanted to help. We hope this app relieves the pressure for both parties, provides fast, exceptional and supportive specialist advice, and increases the number of pets and owners who can benefit from specialist input."
The new app, which will be available for both IOS and Android, will launch at BSAVA Congress 2021, with pre-registration available prior to the launch on 25th March.
To discuss rates and credit options, email: info@vet-com.com.
Cranial cruciate ligament insufficiency (CCLI) affects 3% to 5% of dogs1.
Past research has demonstrated satisfactory short (6-12 weeks)2 and medium (mean 16 months)3 term outcomes for lame dogs treated with TTA.
However, Steve says there is limited research on longer (>16 months) follow-up periods.
It has also been speculated that dogs with tibial plateau angles (TPA) of greater than 30⁰ are not well suited for a TTA4.
For the study5, the researchers reviewed patient records for a total of 149 TTA-Rapid procedures carried out in 120 dogs over an 80 month period.
They also reviewed owner questionnaires that evaluated the outcome of at least six months after surgery, using a validated clinical metrology instrument, Liverpool Osteoarthritis in Dogs (LOAD).
Follow-up questionnaires were received from owners of 64 of the 120 dogs (53.3%), with a median follow-up time of 37.5 months.
This cohort included a wide range of breeds, aged between 2&12 years and with bodyweights ranging from 6.3 to 41.8kg.
The dogs included 37 females and 27 males, and of the 79 limbs treated in these dogs, 41 were left and 38 were right.
The researchers found 26 of the dogs (40.6%) had a TTA performed with a TPA less than 30◦ and 38 (59.4%) with a TPA of 30◦ or more.
Of the 79 procedures, meniscal injury was noted in 27 (34.2%), surgery to stabilise the patella was required in 11 (13.9%), there was one surgical site infection (treated successfully with a short course of antibiotics), one dog sustained a fracture of the tibial seven days after surgery, and one sustained a late meniscal tear 12 months after initial surgery (treated successfully by partial meniscectomy).
The outcome was judged to be satisfactory, based on frequency of lameness, in 63 (98.4%), while satisfactory outcomes were achieved in 61 (95.3%) based on severity of lameness and in 50 (78.1%) based on mobility score.
Statistical analysis showed that age, bodyweight, tibial plateau angle (TPA), meniscal injury, and concurrent patellar surgery did not influence the outcome, but time to follow-up positively correlated with mobility score (suggesting mobility declined with time from surgery).
The researchers concluded that the long-term (median of 37.5 months) outcome for dogs undergoing TTA-Rapid for cranial cruciate ligament disease is satisfactory, with no risk factors associated with poorer outcomes identified.
The study also revealed no evidence to support the suggestion that dogs with TPAs of greater than 30◦ may be inappropriate candidates for TTA - after testing several parameters to judge outcome including frequency of lameness, severity of lameness, distance walked daily and mobility score.
Steve said: “This research is important in trying to ensure that decisions on whether to use this treatment modality, are based on sound clinical evidence.
"The only factor identified that influenced the outcome measure was that of time since surgery.
"All other factors, including TPA, had no effect on the outcome.”
References